Tenet Healthcare Said To Be Exploring Sale: How Far Is Management Willing To Go?

Start generating passive income through real estate.

Own a piece of your favorite cities through diversified real estate investments in the country's top markets

*Terms and conditions apply. Visit Nada's website for more details.

Loading...
Loading...
Shares of
Tenet Healthcare Corp
THC
were trading higher by nearly 3 percent after Thursday's opening bell in reaction to
reports that the company is exploring strategic alternatives, including a potential sale of itself.

However, investors holding on to Tenet's stock under the assumption the company will be bought out at a notable premium may need to reconsider, at least according to KeyBanc Capital Markets' Jason Gurda.

It is "unlikely" that Tenet Healthcare will sell itself given a high level of debt and lack of interest among potential strategic buyers, Gurda commented in a research report (see his track record here). At a $16 billion enterprise valuation, there are few companies that can even afford the price tag for a slow growth hospital company with possible exceptions being HCA Healthcare Inc HCA and maybe Universal Health Services, Inc. UHS.

However, HCA's M&A activity has historically focused on expanding in specific geographic regions and buying Tenet Healthcare would result in a significant overlap in several markets, the analyst noted. Also, Universal Health Services may not have an appetite for new M&A deals after adding new debt to its balance sheet. But what Tenet Healthcare could reasonably oversee to create value for investors is divesting individual hospitals and/or its Conifer subsidiary. Either action would be accretive to Tenet Healthcare's stock and accelerate de-leveraging.

However, it is unclear at this point "how far management is willing to go in breaking up the business."

Related Links: Wall Street's M&A Chatter From September 13: Tenet, Potash, Oclaro, Lattice Semiconductor 5 Stocks To Watch For September 14, 2017
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorNewsHealth CareRumorsM&AAnalyst RatingsMoversGeneralReal Estatehealthcarehealthcare stockshospitalsJason Gurda
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...